Morning Market Movers

BG Medicine

rose 13.52% to $1.93 after the company reported clinical utility of BGM galectin-3 test. Spherix

shares gained 11.90% to $4.70. The gain in shares may be attributed to Markman Advisors tweet: “$SPEX $CSCO Spherix files new case against Cisco asserting 11 patents covering variety of technologies.” Vertex Energy

shares jumped 9% to $6.54 after the company reported a 115% y/y surge in its fiscal 2013 net income. The company's net income jumped to to $7.88 million last year. Cache

rose 9.38% to $4.20 on Q4 results. Cache reported a Q4 loss of $0.17 per share on revenue of $55.80 million. Exa

shares gained 8.20% to $15.05 after the company reported Q4 results. Exa reported its Q4 earnings of $0.03 on revenue of $15.20 million. Baird upgraded the stock from Neutral to Outperform and raised the price target from $16.00 to $17.00. Sonic

climbed 7.93% to $22.58 after the company reported better-than-expected fiscal second-quarter earnings. Sonic posted its quarterly earnings of $0.07 per share on revenue of $109.7 million. However, analysts were projecting a profit of $0.06 per share on revenue of $110.3 million. Endocyte

shares jumped 7.53% to $29.27 after Wedbush added the stock to Best Ideas List and raised the price target to $65. Exelixis

climbed 4.30% to $6.54 as the company received the European Union approval for Cometriq for treatment of progressive thyroid carcinoma. Ariad Pharmaceuticals

jumped 3.29% to $7.85 after HC Wainwright resumed coverage on the stock with a Buy rating and a price target of $14. Walgreen Co

rose 3.42% to $66.51 after the company reported a drop in its second-quarter profit and announced its plans to close 76 stores.